CELATOR PHARMACEUTICALS

Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

#SimilarOrganizations #People #Financial #Website #More

CELATOR PHARMACEUTICALS

Social Links:

Linkedin

Industry:

Biopharma Biotechnology Health Care Health Diagnostics Medical Pharmaceutical

Founded:

1999-01-01

Address:

Princeton, New Jersey, United States

Country:

United States

Website Url:

http://www.celatorpharma.com

Total Employee:

11+

Status:

Active

Contact:

(609) 243-0123

Email Addresses:

[email protected]

Total Funding:

131.88 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Wix Hosted Proofpoint CSC Global DNS

Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

sorrento-therapeutics-logo

Sorrento Therapeutics

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

Current Advisors List

nicole-vitullo_image

Nicole Vitullo Board of Directors @ Celator Pharmaceuticals
Board_member

kenneth-galbraith_image

Kenneth Galbraith Board of Directors @ Celator Pharmaceuticals
Board_member

alex-zisson_image

Alex Zisson Board Member @ Celator Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

Lawrence Mayer
Lawrence Mayer Founder, President & CSO @ Celator Pharmaceuticals
Founder, President & CSO
2014-01-01

derek-miller_image

Derek Miller
Derek Miller CBO @ Celator Pharmaceuticals
CBO
2014-01-01

not_available_image

Arthur C. Louie
Arthur C. Louie CMO @ Celator Pharmaceuticals
CMO
2014-01-01

not_available_image

Scott Jackson
Scott Jackson CEO @ Celator Pharmaceuticals
CEO

Founder

not_available_image

Lawrence Mayer

Stock Details

Company's stock symbol is NASDAQ:CPXX

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Debt Financing - Celator Pharmaceuticals

roth-capital-partners_image

ROTH Capital Partners

ROTH Capital Partners investment in Private Equity Round - Celator Pharmaceuticals

valence-life-sciences_image

Valence Life Sciences

Valence Life Sciences investment in Private Equity Round - Celator Pharmaceuticals

ventures-west_image

Ventures West

Ventures West investment in Series D - Celator Pharmaceuticals

tl-ventures_image

TL Ventures

TL Ventures investment in Series D - Celator Pharmaceuticals

quaker-bioventures_image

Quaker BioVentures

Quaker BioVentures investment in Series D - Celator Pharmaceuticals

domain-associates_image

Domain Associates

Domain Associates investment in Series D - Celator Pharmaceuticals

growthworks_image

GrowthWorks Capital

GrowthWorks Capital investment in Series D - Celator Pharmaceuticals

bdc-venture-capital_image

BDC Venture Capital

BDC Venture Capital investment in Series D - Celator Pharmaceuticals

thomas-mcnerney-partners_image

Thomas, McNerney & Partners

Thomas, McNerney & Partners investment in Series D - Celator Pharmaceuticals

Official Site Inspections

http://www.celatorpharma.com

Host Informations
Whois Informations

Loading ...

More informations about "Celator Pharmaceuticals" on Search Engine